SEC Form 4 · accession 0002153052-26-000002
CME GROUP INC. · CME
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Clifford Marchese
Officer — Sr MD, General Counsel
Period of report
Sep 15, 2026
Accepted (ET)
Sep 17, 2026 · 4:23 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001156375
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock Class A | Sep 15, 2026 | A | 784 | $275.09 | A | 3,839 | D | |
| Common Stock Class A | Sep 15, 2026 | F | 43 | $275.09 | D | 3,796 | D | |
| Common Stock Class A | Sep 15, 2026 | F | 47 | $275.09 | D | 3,749 | D | |
| Common Stock Class A | Sep 15, 2026 | F | 57 | $275.09 | D | 3,692 | D | |
| Common Stock Class A | Sep 15, 2026 | F | 50 | $275.09 | D | 3,642 | D | |
| Common Stock Class A | Sep 16, 2026 | F | 44 | $272.46 | D | 3,598 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. This grant was determined based on the Reporting Person's role as of September 1, 2026 and prior to the effective date of his promotion to Senior Managing Director and General Counsel on September 11, 2026. Under CME Group's compensation program, the Reporting Person is entitled to a promotion-related equity grant in March 2027, which would be reported on a subsequent Form 4.
- F2Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.